This call is closed / A convocatória está encerrada
*Portuguese see below*
The EmpowHER Fund envisions a world where women and girls in all their diversity can truly use the HIV-prevention method of their choice. Yet, in sub-Saharan Africa girls and young women still bear the greatest burden of HIV infections, accounting for nearly 63% of all new infections, with those aged 15–24 being particularly vulnerable. Too many of them, especially those experiencing intersecting vulnerabilities, face limited options to prevent themselves from HIV, leaving them stuck with methods that don’t fit their lives or worse, no methods at all. New and emerging HIV-prevention options, including the 6-monthly Lenacapavir, the two- monthly Apretrude, the Dual Prevention Pill and the Dapivirine vaginal ring, offer a critical opportunity to expand choice and make sure women and girls find the method that best fit their needs.
However, choice isn’t just about having these products available.
It’s about giving women and girls the knowledge, confidence, and power to make decisions and to demand the prevention methods they want. It’s about creating safe, stigma-free services, backed by policies and systems that truly protect and prioritize women’s health. And it’s about centering the leadership of women and girls, ensuring they are the ones shaping the HIV-prevention landscape themselves.
Through this call Aidsfonds invites organisations led by women- and girls, to submit proposals that drive community-led action to advance choice, accelerate access to new and existing HIV- prevention methods and women- and girls leadership in South Africa, Zambia, Kenya, Uganda, and/or Mozambique, to turn EmpowHER’s vision into reality.
Download the full call for proposals and the application form here. Find here access to the Good Grants application platform.
The call is closed.
O Fundo EmpowHER imagina um mundo onde mulheres e raparigas em toda a sua diversidade possam realmente usar o método de prevenção do VIH de sua escolha. No entanto, na África Subsaariana, as raparigas e as mulheres jovens ainda suportam o maior fardo das infeções por VIH, representando quase 63% de todas as novas infeções, sendo as mulheres com idades entre 15 e 24 anos particularmente vulneráveis. Muitas delas, especialmente aquelas que enfrentam vulnerabilidades cruzadas, têm opções limitadas para se protegerem do VIH, ficando presas a métodos que não se adequam às suas vidas ou, pior ainda, sem nenhum método. As opções novas e emergentes de prevenção do VIH, incluindo o Lenacapavir semestral, o Apretrude bimestral, a pílula de prevenção dupla e o anel vaginal Dapivirine, oferecem uma oportunidade crítica para expandir as opções e garantir que as mulheres e raparigas encontrem o método que melhor se adapta às suas necessidades.
No entanto, a escolha não se resume apenas à disponibilidade desses produtos.
Trata-se de dar às mulheres e raparigas o conhecimento, a confiança eo poder para tomar decisões e exigir os métodos de prevenção que desejam. Trata-se de criar serviços seguros e livres de estigma, apoiados por políticas e sistemas que realmente protejam e priorizem a saúde das mulheres. E trata-se de centrar a liderança das mulheres e raparigas, garantindo que sejam elas próprias a moldar o panorama da prevenção do VIH.
Através deste convite, a Aidsfonds convida organizações lideradas por mulheres e raparigas a apresentarem propostas que impulsionem ações lideradas pela comunidade para promover a escolha, acelerar o acesso a métodos novos e existentes de prevenção do VIH e a liderança de mulheres e raparigas na África do Sul, Zâmbia, Quénia, Uganda e/ou Moçambique, a fim de transformar a visão da EmpowHER em realidade.
Descarregue aqui o convite à apresentação de propostas completo e o formulário de candidatura.
Link para Good Grants.
A convocatória está encerrada.
Investing €800 million in the Global Fund doesn't just prevent and treat deadly diseases - it secures the future for up to 1.2 million people facing AIDS, tuberculosis and malaria. That's more than the entire population of Brussels. This is the impact of European action.
Read more
On November 21, donors fell short of the Global Fund’s USD 18 billion target - a disappointing outcome at a time when increased support for HIV, TB and malaria is urgently needed. Now, 330 organisations worldwide are urging the European Commission to confirm a €800 million pledge ahead of the February 2026 Board Meeting. This would help ensure timely funding for country programmes and unlock €400 million in US matching funds. The Nov. 21 outcome fell short, but a stronger result is still possible - and the European Commission and EU Member States can play a key role, in line with Europe’s leadership in global health.
Read more
